Subscribe To
Aclaris therapeutics to participate in two june healthcare investor conferences
WAYNE, Pa., June 02, 2023 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage bio...
June 2, 2023, 11:00 am
Why lexicon pharmaceuticals stock crashed this week
With a new heart failure drug in hand, Lexicon pharmaceuticals decided to raise capital this week, caus...
June 2, 2023, 9:21 am
Why is kiora pharmaceuticals (kprx) stock down 49% today?
Kiora pharmaceuticals (NASDAQ: KPRX ) stock is falling hard on Friday after the company revealed detail...
June 2, 2023, 9:04 am
Praxis precision medicines to present at the 2023 jefferies healthcare conference
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage bio...
June 2, 2023, 9:00 am
4 solid profitable stocks to invest in using net income ratio
Tecnoglass (TGLS), Amphastar pharmaceuticals (AMPH), Turkcell Iletisim Hizmetleri (TKC) and Copa Holdin...
June 2, 2023, 8:53 am
Savara to present at the jefferies healthcare conference
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company ...
June 2, 2023, 8:05 am
Inozyme pharma to present at the jefferies healthcare conference
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease bio...
June 2, 2023, 7:30 am
Kalvista pharmaceuticals to present data at the 2023 meeting of the european academy of allergy and clinical immunology (eaaci)
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista pharmaceuticals, Inc. (NASDA...
June 2, 2023, 6:30 am
Terns pharmaceuticals: upcoming obesity data is one of many catalysts coming up
Terns pharmaceuticals has a promising pipeline with potential best-in-class therapies for obesity and N...
June 1, 2023, 6:47 pm
Why shares of disc medicine opco climbed this week
Disc Medicine is a clinical-stage biopharmaceutical company specializing in treating blood disorders. T...
June 1, 2023, 3:10 pm
Dyadic to participate at upcoming events in june
JUPITER, Fla., June 01, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnolo...
June 1, 2023, 12:30 pm
Panbela announces poster presentation at immunology of diabetes society meeting: evaluating the potential of cpp-1x (eflornithine) in recent onset type 1 diabetes
MINNEAPOLIS, June 01, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage bio...
June 1, 2023, 12:15 pm
Madrigal pharmaceuticals announces participation at two upcoming investor conferences
CONSHOHOCKEN, Pa., June 01, 2023 (GLOBE NEWSWIRE) — Madrigal pharmaceuticals, Inc. (NASDAQ: MDGL), a ...
June 1, 2023, 12:00 pm
Does phathom pharmaceuticals, inc. (phat) have the potential to rally 81.38% as wall street analysts expect?
The mean of analysts' price targets for Phathom pharmaceuticals, Inc. (PHAT) points to an 81.4% upside ...
June 1, 2023, 11:05 am
Clearside biomedical opens enrollment in odyssey phase 2b clinical trial of cls-ax (axitinib injectable suspension) in wet amd
– U.S. Clinical Sites Screening Treatment-Experienced Participants with Wet AMD – – ODYSSEY Topline Results Expected in Q3 2024 – ALPHARETTA, ...
June 1, 2023, 11:05 am
3 reliable dividend growth stocks to buy hand over fist in june
Now that Johnson & Johnson has spun off its slow-moving consumer health division, its pharmaceutical an...
June 1, 2023, 5:37 am
Medivir to present at the redeye growth day
STOCKHOLM , June 1, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company ...
June 1, 2023, 3:09 am
Oncternal therapeutics to participate at the 2023 jefferies healthcare conference
SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage bio...
May 31, 2023, 9:00 pm
Supernus to participate in the jefferies healthcare conference
ROCKVILLE, Md., May 31, 2023 (GLOBE NEWSWIRE) — Supernus pharmaceuticals, Inc. (Nasdaq: SUPN), a bio<...
May 31, 2023, 8:15 pm
Landos biopharma to present at the 2023 jefferies healthcare conference
NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) — Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmac...
May 31, 2023, 8:15 pm